Genpact Limited Common Stock (G)

FairStock Score: 73/100 — STEADY

Key Financials

Strengths

• Generates $768 million in annual free cash flow (13.2% yield on market cap)
• High return on equity of 22.4% demonstrating efficient capital deployment
• Attractive 2.1% dividend yield providing steady income returns
• FairStock composite score of 73/100 places it in the top tier across value, quality, and momentum factors
• Established organization with 1,46,500 employees providing operational scale

AI Analysis

Genpact Limited Common Stock is a small-cap technology company valued at $5.8 billion. The business generates $5.1 billion in annual revenue with a 2.8% net margin and $768 million in free cash flow. From a quality standpoint, Genpact shows solid Piotroski F-Score of 6/9 and Altman Z-Score of 1.9 in the grey zone. On valuation, the stock is attractively valued at 11.0x earnings, with trades above its Graham Number with a negative 6% margin. Growth dynamics show revenue growing at 5.7% and profit growth of 0.8%. The 2.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 73/100 reflects above-average fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates Genpact's consistent 22% ROE at just 11x earnings—a re-rating toward sector peers could unlock 30-50% upside. With $768 million in annual free cash flow (13.2% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the technology space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer